Summary
Twenty-two middle-aged women with severe osteoporosis were treated for 2 years with either 0.5 mg of synthetic human calcitonin subcutaneously three times per week combined with 0.5 μg of calcitriol and 0.5 g of calcium per day orally or calcium only. The treatment with calcitonin plus calcitriol (12 patients) resulted in a significantly increased calcium absorption rate. The mean values for serum phosphate did not change during the treatment period and the mean values did not differ between the treatment groups, but the serum calcium and urinary Ca/Cr ratio increased somewhat in the group given the combined treatment. There was no evidence that the combined treatment improved the bone density in this study. It is possible that calcitriol, instead of increasing the effect of calcitonin by suppression of the parathyroid, might have counteracted its effect by increasing the bone resorption.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Citivelli R, Gonnelli S, Zacchei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C (1988) Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest 82:1268–1274
Reginster JY, Albert A, Lecart MP, Lambellin P, Denis D, Deroisy D, Fontaine MA, Franchimont P (1987) 1-year controlled randomized trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet:1481–1483
Russell J, Lettiere D, Sherwood LM (1986) Suppression by 1,25(OH)2 D3 of transcription of the pre-proparathyroid gene. Endocrinology 119:2864–2866
Marshall DH (1976) Calcium and phosphate kinetics. In: Nordin BEC (ed) Calcium phosphate and magnesium metabolism. Churchill-Livingstone
Bailey NTJ (1969) Statistical methods in biology. Unibooks, English University Press, London
Ott SM, Chestnut CH III (1989) Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Int Med 110:267–274
Jensen GF, Meinecke B, Boesen J, Transböl IB (1985) Does 1,25(OH)2-D3 accelerate bone loss? Clin Orthop Rel Res 192:215–221
Aloia JF, Vaswani A, Yeh JK, Ellis K, Yasumura S, Cohn SH (1988) Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 84:401–408
Gallagher JC, Jerpbak CM, Jee WSS, Johnson KA, DeLuca HF, Riggs BL (1982) 1,25-dihydroxyvitamin D3; short and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. Proc Natl Acad Sci USA 79:3325–3329
Tilyard MW, Spears GFS, Thomson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326:357–362
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eriksson, S.A.V., Lindgren, J.U. Combined treatment with calcitonin and 1,25-dihydroxyvitamin D3 for osteoporosis in women. Calcif Tissue Int 53, 26–28 (1993). https://doi.org/10.1007/BF01352011
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01352011